THE US Food and Drug Administration has approved Giapreza (angiotensin II) injection for intravenous infusion from La Jolla Pharmaceuticals, to increase blood pressure in adults with septic or other distributive shock.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Jan 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Jan 18